MRNA
$26.71
Revenue | $1016Mn |
Net Profits | $-200Mn |
Net Profit Margins | -19.69% |
Moderna, Inc.’s revenue fell -45.23% since last year same period to $1016Mn in the Q3 2025. On a quarterly growth basis, Moderna, Inc. has generated 615.49% jump in its revenue since last 3-months.
Moderna, Inc.’s net profit fell -1638.46% since last year same period to $-200Mn in the Q3 2025. On a quarterly growth basis, Moderna, Inc. has generated 75.76% jump in its net profits since last 3-months.
Moderna, Inc.’s net profit margin fell -2908.9% since last year same period to -19.69% in the Q3 2025. On a quarterly growth basis, Moderna, Inc. has generated 96.61% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -2.05 |
EPS Estimate Current Year | -2.05 |
Moderna, Inc.’s earning per share (EPS) estimates for the current quarter stand at -2.05 - a 31.21% jump from last quarter’s estimates.
Moderna, Inc.’s earning per share (EPS) estimates for the current year stand at -2.05.
Earning Per Share (EPS) | 0 |
Moderna, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Moderna, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-01 | -2.98 | -2.13 | 28.52% |
2025-11-06 | -2.05 | 0 | 100% |
2025-05-01 | -3.03 | -2.52 | 16.83% |